Microglia actions in Alzheimer’s disease

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia, the brain’s intrinsic myeloid cells, are implicated in neurodegenerative disease pathogenesis.
• In Alzheimer’s disease (AD), microglia accumulate around amyloid-beta (Aβ) plaques, contributing to neuroinflammation.
• The precise role and phenotype of microglia in AD progression remain incompletely understood.

Purpose of the Study:

• To explore the multifaceted role of microglia in Alzheimer’s disease pathogenesis.
• To investigate the interaction between microglia and amyloid-beta plaques.
• To highlight microglia as a potential therapeutic target for AD.

Main Methods:

• Review of existing literature on microglia in neurodegenerative diseases.
• Analysis of studies involving patient-derived mutations and mouse models.
• Examination of the microglial response to amyloid-beta deposits in vivo.

Main Results:

• Microglia are identified as key modulators in the progression of neurodegenerative diseases.
• The microglial response to amyloid-beta plaques in AD is complex and may not effectively clear plaques.
• Evidence suggests microglia may lose beneficial functions and adopt detrimental phenotypes in AD.

Conclusions:

• Microglia are central to AD pathogenesis, exhibiting a complex and evolving role.
• Targeting microglia or their secreted factors presents a promising, albeit challenging, avenue for AD therapeutics.
• Further research into microglial function and modulation is crucial for advancing AD treatment strategies.